瑞普生物 (300119)
Tianjin Ringpu Bio-Technology Co.,Ltd.
K-Line Chart
No K-line data available
Company NameRuiPu Biotechnology Co., Ltd.
Listing Date2010-09-17
Issue Price60RMB
Registered Capital46584.790610k RMB
Legal RepresentativeLi Shoujun
Registered AddressNo. 1 Dongjiu Avenue, Airport Economic Zone, China (Tianjin) Pilot Free Trade Zone
IndustryAnimal Health II
Main BusinessResearch, development, production, sales, and technical services of veterinary biological products and veterinary preparations.
Company ProfileRuiPu Biotech is a leading enterprise in China's animal health products industry and a listed company on the Chinese A-share market focusing on the veterinary drug sector. It has been recognized by national industry associations as a "Top 10 Veterinary Biological Products Enterprise" and a "Top 30 Veterinary Drug Preparations Enterprise." RuiPu Biotech's products have been certified as "Tianjin Famous Brand Products." The "RuiPu" trademark has been selected as the "Most Influential Brand in China's Animal Health Industry in 2006," "Influential Brand in Animal Husbandry in 2009," and "Most Influential Brand in National Animal Husbandry Commemorating 30 Years of Reform and Opening-up." With abundant achievements in scientific and technological innovation, it has become a "Leading Enterprise in China's Animal Husbandry and Veterinary Science and Technology Innovation."
Stock Details
1. Key Indicators
- Total Shares(W): 46475.47
- Circulating A-Shares(W): 33496.20
- Earnings Per Share(RMB): 0.7972
- Net Assets Per Share(RMB): 10.0551
- Operating Revenue(W RMB): 254432.50
- Total Profit(W RMB): 44050.93
- Net Profit Attributable to Parent(W RMB): 36230.71
- Net Profit Growth Rate(%): 48.04
- Weighted Return on Equity(%): 7.9300
- Operating Cash Flow Per Share(RMB): 0.4430
- Undistributed Profit Per Share(RMB): 4.3314
- Capital Reserve Per Share(RMB): 4.6326
2. Main Business
The main business covers:
- R&D, production, and sales of veterinary biological products
- R&D, production, and sales of veterinary drug preparations (chemical drugs, traditional Chinese veterinary drugs, disinfectants, etc.)
- R&D, production, and sales of veterinary APIs (active pharmaceutical ingredients)
- R&D, production, and sales of veterinary functional additives
- Integrated animal disease prevention and control solutions
3. Company Basic Information
- Company Name: Tianjin Ringpu Bio-technology Co., Ltd.
- Listing Date: 2010-09-17
- Industry: Agriculture, Forestry, Animal Husbandry & Fishery - Animal Health (Tongdaxin Research Industry) / Pharmaceutical Manufacturing (CSRC Industry)
- Address: No.1 Dongjiu Road, Tianjin Airport Economic Area, Tianjin, China
- Website: www.ringpu.com
- Company Profile: The company was established as a joint-stock company through the overall restructuring of Ringpu Co., Ltd. based on the net assets audited by Zhongrui Yuehua as of December 31, 2007. On May 19, 2008, the company completed the industrial and commercial change registration procedures at the Tianjin Administration for Industry and Commerce, with registration number 120000000002314. Prior to this issuance, the company's registered capital was 55.548 million RMB, and its domicile was Room 713, 7th Floor, Science and Technology Building, Building 3, Crown Plaza, Tianjin Airport Economic Area.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Guotai Zhongzheng Livestock Breeding ETF | Fund | 633.83 | 1.89 |
| 2 | Shanghai Axing Investment Management Co., Ltd. - Axing Gezhi No.7 Private Securities Investment Fund | Private Securities Investment Fund | 460.00 | 1.37 |
| 3 | National Social Security Fund 604 Portfolio | Social Security Fund | 400.00 | 1.19 |
| 4 | Turing Private Fund Management (Hainan) Co., Ltd. - Turing Maitian No.6 Private Securities Investment Fund | Private Securities Investment Fund | 361.33 | 1.08 |
| 5 | Hong Kong Securities Clearing Company Ltd. (Northbound) | Northbound Capital | 360.17 | 1.08 |
| 6 | Changan Xinyue Consumption Driven Hybrid Securities Investment Fund Class A | Fund | 60.00 | 0.18 |
| 7 | Hua'an ChiNext Two-Year Regular Open Hybrid Securities Investment Fund | Fund | 30.13 | 0.09 |
| 8 | Tongtai Huize Hybrid Securities Investment Fund Class A | Fund | 3.90 | 0.01 |
5. Concept Sectors
- Biological Vaccines
- Synthetic Biology
- Pet Economy
- High-Performance Stocks
- Newly Added by Social Security Fund
- Special Loans
- ChiNext 300
- ChiNext Innovation
- Agriculture 50
- ChiNext Small Cap
Remarks
- Data update date: 2026-01-01
- Data source: Public Market Information
